Safety & Clinical Outcomes
This area of focus investigates what happens when treatments and medications are used in real-world care.
Our work examines whether emerging and established therapies are safe, how their benefits and risks may differ across patients, and how mental health treatment can intersect with broader physical health concerns.
RELEVANT PUBLICATIONS
Are the current safety measures for the treatment of depression with esketamine sufficient? Valentino K, Teopiz K, Dri C, Swainson J, …. McIntyre RS. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2026.2627184
Effects of antidepressants in cardiovascular disease: Cardiovascular safety and efficacy in randomized trials. Ho A., Adams G., Abdelaal A., Valentino K. Brain & Heart 025380051. https://doi.org/10.36922/BH025380051
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Measures of Suicidality: A Systematic Review. Valentino K, Teopiz K, Cheung W … McIntyre RS (2025). Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2025.02.008